![David Altarac](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Altarac
Technik-/Wissenschafts-/F&E-Leiter bei
ENTASIS THERAPEUTICS HOLDINGS INC.
Profil
David Altarac is currently the Chief Medical Officer at Entasis Therapeutics, Inc. and Entasis Therapeutics Holdings, Inc. He previously held positions as SVP & Head-Regulatory, Safety & Compliance at Shire Plc, Vice President-Regulatory Affairs at NeoStem, Inc., and Vice President-Regulatory Affairs at Caladrius Biosciences, Inc. Altarac has a graduate degree from New York University, a doctorate from New York Medical College, an undergraduate degree from State University of New York at Binghamton, and a graduate degree from NYU Wagner.
Aktive Positionen von David Altarac
| Unternehmen | Position | Beginn |
|---|---|---|
| ENTASIS THERAPEUTICS HOLDINGS INC. | Technik-/Wissenschafts-/F&E-Leiter | 04.11.2019 |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Technik-/Wissenschafts-/F&E-Leiter | 04.11.2019 |
Ehemalige bekannte Positionen von David Altarac
| Unternehmen | Position | Ende |
|---|---|---|
NeoStem, Inc. /Old/
 NeoStem, Inc. /Old/ Other TransportationTransportation Operates a commercial autologous adult stem cell bank | General Counsel | 01.06.2015 |
| SHIRE | Compliance Officer | - |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | General Counsel | - |
Ausbildung von David Altarac
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
9
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York Medical College
 New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeoStem, Inc. /Old/
NeoStem, Inc. /Old/ Other TransportationTransportation Operates a commercial autologous adult stem cell bank | Transportation |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Health Technology |
State University of New York at Binghamton
 State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NYU Wagner
 NYU Wagner Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Health Technology |
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biopharmaceutical company that engages in development of antibacterial products | Commercial Services |
